Tildipirosin injection is indicated for the treatment and control of respiratory diseases in cattle and swine.
INDICATIONS
Cattle (Bovine Respiratory Disease – BRD)
Tildipirosin is indicated for the treatment of BRD and the control (prevention) of respiratory disease in cattle at high risk of developing BRD. It is effective against bacterial pathogens such as Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni.
Swine (Swine Respiratory Disease – SRD)
In swine, tildipirosin is indicated for the treatment and metaphylaxis (control/prevention in a group) of SRD associated with bacteria like Actinobacillus pleuropneumoniae, Pasteurella multocida, Bordetella bronchiseptica, and Haemophilus parasuis.
ADMINISTRATION
- Tildipirosin is administered as a single subcutaneous injection in cattle, and as an intramuscular injection in swine.
- Contraindications:
- It is specifically contraindicated and fatal adverse events have been reported in swine when the cattle formulation (180 mg/mL) is used, and vice versa for the swine formulation.
- Do not use in female dairy cattle 20 months of age or older or in calves intended for veal.
- Do not use concurrently with other macrolides or lincosamides, as cross-resistance may occur.
Reviews
There are no reviews yet.